Correlation Between Theravance Biopharma and Neoleukin Therapeutics
Can any of the company-specific risk be diversified away by investing in both Theravance Biopharma and Neoleukin Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Theravance Biopharma and Neoleukin Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Theravance Biopharma and Neoleukin Therapeutics, you can compare the effects of market volatilities on Theravance Biopharma and Neoleukin Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Theravance Biopharma with a short position of Neoleukin Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Theravance Biopharma and Neoleukin Therapeutics.
Diversification Opportunities for Theravance Biopharma and Neoleukin Therapeutics
-0.35 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Theravance and Neoleukin is -0.35. Overlapping area represents the amount of risk that can be diversified away by holding Theravance Biopharma and Neoleukin Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neoleukin Therapeutics and Theravance Biopharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Theravance Biopharma are associated (or correlated) with Neoleukin Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neoleukin Therapeutics has no effect on the direction of Theravance Biopharma i.e., Theravance Biopharma and Neoleukin Therapeutics go up and down completely randomly.
Pair Corralation between Theravance Biopharma and Neoleukin Therapeutics
If you would invest 1,396 in Neoleukin Therapeutics on March 6, 2024 and sell it today you would earn a total of 0.00 from holding Neoleukin Therapeutics or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 5.0% |
| Values | Daily Returns |
Theravance Biopharma vs. Neoleukin Therapeutics
Performance |
| Timeline |
| Theravance Biopharma |
| Neoleukin Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Theravance Biopharma and Neoleukin Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |